메뉴 건너뛰기




Volumn 50, Issue 6 SUPPL. 1, 2005, Pages

Safety of moxifloxacin as shown in animal and in vitro studies

Author keywords

Fluoroquinolone; Moxifloxacin; Nonclinical safety; Safety pharmacology; Toxicity; VIGAMOX

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

EID: 27844583146     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2005.05.003     Document Type: Article
Times cited : (30)

References (19)
  • 1
    • 22444449079 scopus 로고    scopus 로고
    • The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy
    • J.M. Burka, K.S. Bower, R.C. Vanrockel, R.D. Stutzman, C.P. Kuzmowych, and R.S. Howard The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy Am J Ophthalmol 140 2005 83 87
    • (2005) Am J Ophthalmol , vol.140 , pp. 83-87
    • Burka, J.M.1    Bower, K.S.2    Vanrockel, R.C.3    Stutzman, R.D.4    Kuzmowych, C.P.5    Howard, R.S.6
  • 2
    • 1542427150 scopus 로고    scopus 로고
    • Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models
    • L. Clark, P. Bezwada, and K. Hosoi Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models J Toxicol Cutan Ocul Toxicol 23 2004 1 18
    • (2004) J Toxicol Cutan Ocul Toxicol , vol.23 , pp. 1-18
    • Clark, L.1    Bezwada, P.2    Hosoi, K.3
  • 3
    • 0025796593 scopus 로고
    • Topical fluoroquinolones: Antimicrobial activity and in vitro corneal epithelial toxicity
    • P.E. Cutarelli, J.H. Lass, and H.M. Lazarus Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity Curr Eye Res 10 1991 557 563
    • (1991) Curr Eye Res , vol.10 , pp. 557-563
    • Cutarelli, P.E.1    Lass, J.H.2    Lazarus, H.M.3
  • 4
    • 10044285893 scopus 로고    scopus 로고
    • A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability
    • E. Donnenfeld, H.D. Perry, and D.A. Chruscicki A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability Curr Med Res Opin 20 2004 1753 1758
    • (2004) Curr Med Res Opin , vol.20 , pp. 1753-1758
    • Donnenfeld, E.1    Perry, H.D.2    Chruscicki, D.A.3
  • 5
    • 21644457591 scopus 로고    scopus 로고
    • A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK
    • Durrie DS, Trattler W: a comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. J Ocular Pharm Ther 21:236-41, 2005
    • (2005) J Ocular Pharm Ther , vol.21 , pp. 236-241
    • Durrie, D.S.1    Trattler, W.2
  • 6
    • 0034786745 scopus 로고    scopus 로고
    • Fluoroquinolone adverse effects and drug interactions
    • D.N. Fish Fluoroquinolone adverse effects and drug interactions Pharmacotherapy 21 2001 S253 S272
    • (2001) Pharmacotherapy , vol.21
    • Fish, D.N.1
  • 8
    • 19944426971 scopus 로고    scopus 로고
    • Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous
    • S.M. Hariprasad, K.J. Blinder, and G.K. Shah Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous Arch Ophthalmol 123 2005 39 44
    • (2005) Arch Ophthalmol , vol.123 , pp. 39-44
    • Hariprasad, S.M.1    Blinder, K.J.2    Shah, G.K.3
  • 9
    • 11144222541 scopus 로고    scopus 로고
    • Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols
    • L.A. Herrygers, R.J. Noecker, and L.C. Lane Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols Cornea 24 2005 66 71
    • (2005) Cornea , vol.24 , pp. 66-71
    • Herrygers, L.A.1    Noecker, R.J.2    Lane, L.C.3
  • 10
    • 0026602579 scopus 로고
    • Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride
    • H. Ichijima, W.M. Petroll, and J.V. Jester Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride Cornea 11 1992 221 225
    • (1992) Cornea , vol.11 , pp. 221-225
    • Ichijima, H.1    Petroll, W.M.2    Jester, J.V.3
  • 11
    • 0035170062 scopus 로고    scopus 로고
    • Interactions of a series of fluoroquinolone antibacterial drugs with human cardiac K+ channel HERG
    • J. Kang, L. Wang, and X. Chen Interactions of a series of fluoroquinolone antibacterial drugs with human cardiac K+ channel HERG Mol Pharmacol 59 2001 122 126
    • (2001) Mol Pharmacol , vol.59 , pp. 122-126
    • Kang, J.1    Wang, L.2    Chen, X.3
  • 12
    • 3242809854 scopus 로고    scopus 로고
    • Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy
    • T. Kovoor, A. Kim, and J. McCulley Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy Eye Contact Lens 30 2004 90 94
    • (2004) Eye Contact Lens , vol.30 , pp. 90-94
    • Kovoor, T.1    Kim, A.2    McCulley, J.3
  • 13
    • 0027301186 scopus 로고
    • Effect of ofloxacin on corneal epithelial wound healing evaluated by in vitro and in vivo methods
    • S. Matsumoto, M. Stern, and R. Oda Effect of ofloxacin on corneal epithelial wound healing evaluated by in vitro and in vivo methods Drug Invest 6 1993 96 103
    • (1993) Drug Invest , vol.6 , pp. 96-103
    • Matsumoto, S.1    Stern, M.2    Oda, R.3
  • 14
    • 0002611505 scopus 로고
    • Ocular pharmacokinetics
    • M.L. Sears Springer-Verlag New York
    • D. Maurice, and S. Mishima Ocular pharmacokinetics M.L. Sears Pharmacology of the Eye 1984 Springer-Verlag New York 19 116
    • (1984) Pharmacology of the Eye , pp. 19-116
    • Maurice, D.1    Mishima, S.2
  • 15
    • 0346998263 scopus 로고    scopus 로고
    • The in vivo effects of fluoroquinolones on rabbit corneas
    • G. Pollack, P. McKelvie, and J. White The in vivo effects of fluoroquinolones on rabbit corneas Clin Experiment Ophthalmol 31 2003 517 521
    • (2003) Clin Experiment Ophthalmol , vol.31 , pp. 517-521
    • Pollack, G.1    McKelvie, P.2    White, J.3
  • 17
    • 0020038842 scopus 로고
    • Pharmacokinetics of topically applied ophthalmic drugs
    • J.W. Shell Pharmacokinetics of topically applied ophthalmic drugs Surv Ophthalmol 26 1982 207 218
    • (1982) Surv Ophthalmol , vol.26 , pp. 207-218
    • Shell, J.W.1
  • 18
    • 27844584957 scopus 로고    scopus 로고
    • In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone
    • D.W. Stroman, J.J. Dajcs, G. Cupp, and B.A. Schlech In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone Surv Ophthalmol 50 Suppl 2005 S16 S31
    • (2005) Surv Ophthalmol , vol.50 , Issue.SUPPL.
    • Stroman, D.W.1    Dajcs, J.J.2    Cupp, G.3    Schlech, B.A.4
  • 19
    • 0345436059 scopus 로고    scopus 로고
    • Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone
    • E. von Keutz, and G. Schlüter Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone J Antimicrob Chemother 43 Suppl B 1999 91 100
    • (1999) J Antimicrob Chemother , vol.43 , Issue.SUPPL. B , pp. 91-100
    • Von Keutz, E.1    Schlüter, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.